RU2018105988A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018105988A3 RU2018105988A3 RU2018105988A RU2018105988A RU2018105988A3 RU 2018105988 A3 RU2018105988 A3 RU 2018105988A3 RU 2018105988 A RU2018105988 A RU 2018105988A RU 2018105988 A RU2018105988 A RU 2018105988A RU 2018105988 A3 RU2018105988 A3 RU 2018105988A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/28—Vascular endothelial cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562194460P | 2015-07-20 | 2015-07-20 | |
| US62/194,460 | 2015-07-20 | ||
| PCT/US2016/042872 WO2017015245A1 (en) | 2015-07-20 | 2016-07-19 | Methods and compositions for stem cell transplantation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018105988A RU2018105988A (ru) | 2019-08-20 |
| RU2018105988A3 true RU2018105988A3 (ru) | 2020-01-21 |
| RU2757818C2 RU2757818C2 (ru) | 2021-10-21 |
Family
ID=57834594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018105988A RU2757818C2 (ru) | 2015-07-20 | 2016-07-19 | Способы и композиции для трансплантации стволовых клеток |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20180214488A1 (ru) |
| EP (2) | EP3325612B1 (ru) |
| JP (2) | JP7089282B2 (ru) |
| KR (1) | KR20180048617A (ru) |
| CN (1) | CN108350419A (ru) |
| AU (2) | AU2016297523B2 (ru) |
| CA (1) | CA2993014A1 (ru) |
| DK (1) | DK3325612T3 (ru) |
| ES (1) | ES2939635T3 (ru) |
| FI (1) | FI3325612T3 (ru) |
| HK (1) | HK1258528A1 (ru) |
| RU (1) | RU2757818C2 (ru) |
| SG (1) | SG10201913752PA (ru) |
| WO (1) | WO2017015245A1 (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10961509B2 (en) | 2015-07-20 | 2021-03-30 | Angiocrine Bioscience, Inc. | Engineered endothelial cells expressing an ETS transcription factor |
| US12012436B2 (en) | 2016-03-23 | 2024-06-18 | The Regents Of The University Of California | Methods of treating mitochondrial disorders |
| US12011488B2 (en) | 2016-03-23 | 2024-06-18 | The Regents Of The University Of California | Methods of treating mitochondrial disorders |
| RU2753441C2 (ru) | 2016-09-13 | 2021-08-16 | Ангиокрин Биосайенс, Инк. | Гематоэнцефалический барьер, содержащий сконструированные эндотелиальные клетки |
| CN110418800A (zh) | 2017-03-15 | 2019-11-05 | 加利福尼亚大学董事会 | 治疗溶酶体紊乱的方法 |
| CN106929469B (zh) * | 2017-04-25 | 2020-08-07 | 徐子雁 | 间充质干细胞分化为表皮细胞的方法及试剂盒 |
| WO2019183508A1 (en) * | 2018-03-23 | 2019-09-26 | The Children's Medical Center Corporation | Endothelial cell factors and methods thereof |
| EP4171593A4 (en) * | 2020-06-25 | 2024-07-03 | Angiocrine Bioscience, Inc. | Endothelial cells for mitigation of chemotherapy-induced toxicity |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2035317T5 (es) | 1987-11-09 | 1998-03-16 | Becton Dickinson Co | Metodo para analizar celulas hematopoyeticas en una muestra. |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5840580A (en) | 1990-05-01 | 1998-11-24 | Becton Dickinson And Company | Phenotypic characterization of the hematopoietic stem cell |
| US6326198B1 (en) | 1990-06-14 | 2001-12-04 | Regents Of The University Of Michigan | Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
| DE4322570C1 (de) * | 1993-07-07 | 1994-06-16 | Gsf Forschungszentrum Umwelt | Stromale Zellinien aus menschlichem Knochenmark |
| US5599703A (en) * | 1993-10-28 | 1997-02-04 | The United States Of America As Represented By The Secretary Of The Navy | In vitro amplification/expansion of CD34+ stem and progenitor cells |
| US5925567A (en) | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
| US6335195B1 (en) | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| US6100086A (en) * | 1997-04-14 | 2000-08-08 | Genzyme Corporation | Transgene expression systems |
| EP1248519A4 (en) | 2000-01-18 | 2004-03-31 | Univ Leland Stanford Junior | EXPANSION OF STEM AND PROCUREMENT CELLS BY BETA-CATENIN |
| WO2002038189A1 (en) * | 2000-11-09 | 2002-05-16 | Mayo Foundation For Medical Education And Research | Absolute lymphocyte recovery and cancer survival |
| AU2002350030A1 (en) * | 2001-10-30 | 2003-05-12 | The United States Of America As Represented By The Secretary Of The Navy | Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injury |
| US7635477B2 (en) * | 2002-07-25 | 2009-12-22 | The General Hospital Corporation | Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| WO2008089448A2 (en) | 2007-01-19 | 2008-07-24 | Cornell Presearch Foundation, Inc. | Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis |
| EP2591093B1 (en) * | 2010-07-07 | 2018-11-28 | FUJIFILM Cellular Dynamics, Inc. | Endothelial cell production by programming |
| EP3278808A1 (en) * | 2010-08-12 | 2018-02-07 | Fate Therapeutics, Inc. | Improved hematopoietic stem and progenitor cell therapy |
| CN102643784B (zh) * | 2012-03-29 | 2016-05-25 | 中国人民解放军第四军医大学 | 一种造血干/祖细胞的体外扩增体系 |
| CN104520422B (zh) * | 2012-05-30 | 2019-08-23 | 康奈尔大学 | 由人羊水来源的细胞生成功能性的和持久的内皮细胞 |
| CA2898180C (en) * | 2013-01-15 | 2023-09-26 | Cornell University | Reprogramming of human endothelium into hematopoietic multi-lineage progenitors by defined factors |
| JP2015109833A (ja) | 2013-11-08 | 2015-06-18 | 学校法人慶應義塾 | 線維芽細胞から血管内皮細胞を製造する方法 |
| SG10201903912XA (en) * | 2014-10-31 | 2019-05-30 | Massachusetts Inst Technology | Delivery of biomolecules to immune cells |
| US10961509B2 (en) * | 2015-07-20 | 2021-03-30 | Angiocrine Bioscience, Inc. | Engineered endothelial cells expressing an ETS transcription factor |
-
2016
- 2016-07-19 WO PCT/US2016/042872 patent/WO2017015245A1/en not_active Ceased
- 2016-07-19 SG SG10201913752PA patent/SG10201913752PA/en unknown
- 2016-07-19 US US15/746,369 patent/US20180214488A1/en not_active Abandoned
- 2016-07-19 CN CN201680053238.8A patent/CN108350419A/zh active Pending
- 2016-07-19 JP JP2018503173A patent/JP7089282B2/ja active Active
- 2016-07-19 EP EP16828392.7A patent/EP3325612B1/en active Active
- 2016-07-19 RU RU2018105988A patent/RU2757818C2/ru active
- 2016-07-19 FI FIEP16828392.7T patent/FI3325612T3/fi active
- 2016-07-19 HK HK19100883.9A patent/HK1258528A1/zh unknown
- 2016-07-19 DK DK16828392.7T patent/DK3325612T3/da active
- 2016-07-19 AU AU2016297523A patent/AU2016297523B2/en active Active
- 2016-07-19 EP EP22206407.3A patent/EP4202036A1/en active Pending
- 2016-07-19 KR KR1020187004650A patent/KR20180048617A/ko active Pending
- 2016-07-19 CA CA2993014A patent/CA2993014A1/en active Pending
- 2016-07-19 ES ES16828392T patent/ES2939635T3/es active Active
-
2022
- 2022-06-03 JP JP2022090788A patent/JP7473984B2/ja active Active
- 2022-07-07 AU AU2022204899A patent/AU2022204899A1/en not_active Abandoned
-
2023
- 2023-09-11 US US18/464,908 patent/US20230414671A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3325612A1 (en) | 2018-05-30 |
| ES2939635T3 (es) | 2023-04-25 |
| WO2017015245A8 (en) | 2022-11-03 |
| RU2757818C2 (ru) | 2021-10-21 |
| FI3325612T3 (fi) | 2023-03-20 |
| DK3325612T3 (da) | 2023-03-06 |
| KR20180048617A (ko) | 2018-05-10 |
| JP2018521074A (ja) | 2018-08-02 |
| JP7473984B2 (ja) | 2024-04-24 |
| EP4202036A1 (en) | 2023-06-28 |
| US20180214488A1 (en) | 2018-08-02 |
| JP7089282B2 (ja) | 2022-06-22 |
| EP3325612B1 (en) | 2022-12-14 |
| EP3325612A4 (en) | 2018-12-26 |
| AU2022204899A1 (en) | 2022-07-28 |
| JP2022121446A (ja) | 2022-08-19 |
| AU2016297523A1 (en) | 2018-02-22 |
| RU2018105988A (ru) | 2019-08-20 |
| WO2017015245A1 (en) | 2017-01-26 |
| AU2016297523B2 (en) | 2022-07-28 |
| US20230414671A1 (en) | 2023-12-28 |
| HK1258528A1 (zh) | 2019-11-15 |
| CN108350419A (zh) | 2018-07-31 |
| SG10201913752PA (en) | 2020-03-30 |
| CA2993014A1 (en) | 2017-01-26 |